NeuroOne Medical Technologies Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NMTC research report →
Companyn1mtc.com
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode.
- CEO
- David A. Rosa
- IPO
- 2018
- Employees
- 17
- HQ
- Eden Prairie, MN, US
Price Chart
Valuation
- Market Cap
- $35.26M
- P/E
- -5.19
- P/S
- 3.63
- P/B
- 6.42
- EV/EBITDA
- -4.90
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 54.50%
- Op Margin
- -72.69%
- Net Margin
- -68.34%
- ROE
- -98.33%
- ROIC
- -112.33%
Growth & Income
- Revenue
- $12.10M · 250.35%
- Net Income
- $-3,605,374 · 70.73%
- EPS
- $-0.54 · 80.43%
- Op Income
- $-4,226,473
- FCF YoY
- 73.78%
Performance & Tape
- 52W High
- $6.96
- 52W Low
- $3.28
- 50D MA
- $4.58
- 200D MA
- $4.73
- Beta
- 0.58
- Avg Volume
- 38.82K
Get TickerSpark's AI analysis on NMTC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 3, 26 | Mills Jason Richard | other | 41,929 |
| Apr 3, 26 | Mills Jason Richard | other | 26,036 |
| Apr 3, 26 | MATHIESEN JEFFREY S | other | 41,929 |
| Apr 3, 26 | MATHIESEN JEFFREY S | other | 26,036 |
| Apr 3, 26 | BUCKMAN PAUL | other | 41,929 |
| Apr 3, 26 | BUCKMAN PAUL | other | 26,036 |
| Apr 3, 26 | Andrle Edward | other | 41,929 |
| Apr 3, 26 | Andrle Edward | other | 26,036 |
| Mar 30, 26 | Christianson Mark | sell | 15,363 |
| Mar 31, 26 | Christianson Mark | other | 253 |
Our NMTC Coverage
We haven't published any research on NMTC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NMTC Report →